Medical specialists from United Kingdom tagged as investigators in clinical trials studying Lymphoma, Large B-Cell, Diffuse
Total 18 results
-
Andrew ClampSeen in:
- Manchester, The Christie NHS Foundation Trust, Department of Medical Oncology
Trials:- NCT04104776 (Principal Investigator)
-
Anna Cowley, MDSeen in:
- Other, Eastbourne, East Sussex Healthcare NHS Trust
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Anna MinchomSeen in:
- England, London, Royal Marsden Hosital, Sutton
- Other, London, The Royal Marsden NHS Foundation Trust (RM)
- Other, Surrey, The Royal Marsden Hospital
- Other, Sutton, The Royal Marsden Hospital (Surrey)
- Surrey, Sutton, Royal Marsden Hospital
- Surrey, The Royal Marsden Hospital
- Sutton, The Royal Marsden Hospital (Surrey)
Trials:- NCT03157128 (Principal Investigator)
- NCT04254107 (Principal Investigator)
- NCT04665921 (Principal Investigator)
- NCT04042480 (Principal Investigator)
- NCT05229900 (Principal Investigator)
- NCT05208762 (Principal Investigator)
- NCT05782361 (Principal Investigator)
Conditions:- Non-Small Cell Lung Cancer;
- Colon Cancer;
- Medullary Thyroid Cancer;
- Any Solid Tumor;
- Cervical Cancer;
- Ovarian Cancer;
- Peripheral T-cell Lymphoma;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Non-small Cell Lung Cancer;
- Head and Neck Squamous Cell Carcinoma;
- Gastric Carcinoma;
- Classical Hodgkin Lymphoma;
- Diffuse Large B-cell Lymphoma;
- Cutaneous Melanoma;
- Gastroesophageal Junction Carcinoma;
- Uterine Cervical Neoplasms;
- Stomach Neoplasms;
- Colorectal Neoplasms;
- Esophageal Neoplasms;
- Ovarian Neoplasms;
- Endometrial Neoplasms;
- Pseudomyxoma Peritonei;
- Carcinoma, Non-Small Cell Lung;
- HER2 Negative Breast Neoplasms;
- Exocrine Pancreatic Adenocarcinoma;
- Appendiceal Adenocarcinoma;
- Colorectal Cancer;
- Pancreatic Ductal Adenocarcinoma;
- Pleural Mesothelioma;
- Testicular Neoplasms;
- Carcinoma, Non-Small-Cell Lung;
- Melanoma;
- Gastric Cancer;
- Squamous Cell Carcinoma of the Head and Neck;
- Triple Negative Breast Neoplasms;
- Esophageal Squamous Cell Carcinoma;
- Non Small Cell Lung Cancer;
- Advanced Cancer
-
David CunninghamSeen in:
- London, Sutton, The Royal Marsden NHS Foundation Trust
- London, The Royal Marsden NHS Foundation Trust
- Other, London, The Royal Marsden Hospital
- Other, Sutton, The Royal Marsden Hospital (Surrey)
- Surrey, Sutton, The Royal Marsden NHS Foundation Trust
Trials:- NCT04420884 (Principal Investigator)
- NCT04404283 (Principal Investigator)
- NCT04166721 (Principal Investigator)
-
Elisa FontanaSeen in:
- London, Sarah Cannon Research Institute
- London, Sarah Cannon Research Institute UK
- Other, London, Sarah Cannon Research Institute UK
Trials:- NCT03526835 (Principal Investigator)
- NCT04254107 (Principal Investigator)
- NCT05194072 (Principal Investigator)
- NCT05229900 (Principal Investigator)
- NCT04389632 (Principal Investigator)
- NCT04657068 (Principal Investigator)
- NCT05208762 (Principal Investigator)
- NCT05327530 (Principal Investigator)
Conditions:- Gastric Cancer;
- Colorectal Cancer;
- NSCLC;
- Head and Neck Squamous Cell Carcinoma;
- HNSCC;
- Advanced/Metastatic Solid Tumors;
- Gastroesophageal-junction Cancer;
- Cervical Cancer;
- Ovarian Cancer;
- Peripheral T-cell Lymphoma;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Non-small Cell Lung Cancer;
- Gastric Carcinoma;
- Classical Hodgkin Lymphoma;
- Diffuse Large B-cell Lymphoma;
- Cutaneous Melanoma;
- Gastroesophageal Junction Carcinoma;
- Carcinoma, Non-Small-Cell Lung;
- Adenoid Cystic Carcinoma;
- Ovarian Neoplasms;
- Fallopian Tube Neoplasms;
- Peritoneal Neoplasms;
- Endometrial Neoplasms;
- Cholangiocarcinoma;
- Triple Negative Breast Neoplasms;
- Gallbladder Carcinoma;
- HER2 Negative Breast Neoplasms;
- Hormone Receptor Positive Breast Neoplasms;
- Uterine Cervical Neoplasms;
- Stomach Neoplasms;
- Testicular Neoplasms;
- Urinary Bladder Neoplasms;
- Squamous Cell Carcinoma of Head and Neck;
- Carcinoma, Non-Small Cell Lung;
- Esophageal Adenocarcinoma;
- Esophageal Squamous Cell Carcinoma;
- Gastroesophageal Junction Adenocarcinoma;
- Exocrine Pancreatic Adenocarcinoma;
- Cutaneous Squamous Cell Cancer;
- Fallopian Tube Cancer;
- Metastatic Cancer;
- Advanced Cancer;
- Primary Peritoneal Cancer;
- Melanoma;
- Squamous Cell Carcinoma of the Head and Neck;
- Locally Advanced or Metastatic Urothelial Carcinoma
-
Emma CattellSeen in:
- Taunton, Musgrove Park Hospital
Trials:- NCT04104776 (Principal Investigator)
-
Graham CollinsSeen in:
- Other, Headington, Oxford University Hospitals
- Oxford, Churchill Hospital
- Oxford, Headington, Oxford Cancer & Haematology Centre, The Churchill Hospital
Trials:- NCT04685616 (Principal Investigator)
- NCT04569032 (Principal Investigator)
- NCT05221645 (Principal Investigator)
-
Harriet Walter, MDSeen in:
- Leicester, University Hospitals of Leicester NHS Trust
Trials:- NCT04104776 (Principal Investigator)
-
Heather ShawSeen in:
- London, University College London Hospital
Trials:- NCT04763083 (Sub-Investigator)
-
John GribbenSeen in:
- London, City Of, London, St Bartholomew's Hospital
- Other, London, St Bartholomew's Hospital
Trials:- NCT04404283 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Lalita BanerjeeSeen in:
- Other, Maidstone, Maidstone and Tunbridge Wells NHS Trust
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Lindsay GeorgeSeen in:
- Other, Edgbaston, Birmingham, University Hospitals Birmingham NHS Foundation Trust
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Martin ForsterSeen in:
- London, University College London Hospital
Trials:- NCT04763083 (Sub-Investigator)
-
Mary GleesonSeen in:
- Other, London, Guy's and St Thomas' NHS Foundation
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Pam McKaySeen in:
- Glasgow, Beatson West of Scotland Cancer Centre
- Glasgow, The Beatson West of Scotland Cancer Centre
- Other, Glasgow, The Beatson West of Scotland Cancer Centre
Trials:- NCT04685616 (Principal Investigator)
- NCT04569032 (Principal Investigator)
- NCT05221645 (Principal Investigator)
-
Rebecca BowenSeen in:
- Bath, Royal United Hospital
Trials:- NCT04104776 (Principal Investigator)
-
Susana BanerjeeSeen in:
- London, City Of, London, The Royal Marsden NHS Foundation Trust
- London, City Of, Sutton, The Royal Marsden NHS Foundation Trust
- London, The Royal Marsden NHS Foundation Trust
- Surrey, Sutton, The Royal Marsden NHS Foundation Trust
- Sutton, Royal Marsden Hospital - Sutton
Trials:- NCT05483933 (Principal Investigator)
- NCT05456685 (Principal Investigator)
- NCT04104776 (Principal Investigator)
Conditions:- Ovarian Cancer;
- Fallopian Tube Cancer;
- Epithelial Ovarian Cancer;
- Platinum-resistant Ovarian Cancer;
- Primary Peritoneal Carcinoma;
- Platinum-Resistant Fallopian Tube Carcinoma;
- Platinum-Resistant Primary Peritoneal Carcinoma;
- Primary Peritoneal Cancer;
- High Grade Ovarian Cancer;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant
-
Unmesh MohiteSeen in:
- Other, Swansea, Singleton Hospital
- Swansea, Singleton Hospital
Trials:- NCT04404283 (Principal Investigator)
- NCT05254743 (Principal Investigator)
Clinical Trials on Lymphoma, Large B-Cell, Diffuse
-
National Cancer Institute (NCI)WithdrawnDiffuse, Large B-cell Lymphoma | Lymphoma, Diffuse Large-Cell | Lymphoma, Diffuse Large-Cell B-cell | Large-Cell Lymphoma, Diffuse
-
Memorial Sloan Kettering Cancer CenterRecruitingLymphoma | Lymphoma, B-Cell | DLBCL - Diffuse Large B Cell Lymphoma | Large B-cell Lymphoma | Large-cell Lymphoma | Mediastinal B-Cell Diffuse Large Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteBayer; AbbVieActive, not recruitingDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); AmgenActive, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | CD20 Positive | Stage I Diffuse Large B-Cell Lymphoma | Stage II Diffuse Large B-Cell Lymphoma | Stage III Diffuse Large B-Cell Lymphoma | Stage IV Diffuse Large B-Cell LymphomaUnited States
-
University Hospital Southampton NHS Foundation...Hoffmann-La RocheTerminatedDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited Kingdom
-
Qian WenbinNot yet recruitingDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaChina
-
Autolus LimitedCompletedDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | DLBCL | Relapsed Diffuse Large B-Cell LymphomaUnited States, United Kingdom
-
Herlev HospitalOdense University Hospital; Zealand University Hospital; Aarhus University Hospital and other collaboratorsCompletedDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma Cell of Origin
-
Memorial Sloan Kettering Cancer CenterSanofi; Columbia University; Medical College of Wisconsin; University of Rochester and other collaboratorsActive, not recruitingDiffuse Large B-cell Lymphoma (DLBCL) | Relapsed Diffuse Large B-cell Lymphoma (DLBCL) | Refractory Diffuse Large B-cell Lymphoma (DLBCL)United States
-
NeoImmuneTechRecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Refractory High Grade B-Cell Lymphoma | Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-cell LymphomaUnited States